Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children

Journal of the American Academy of Dermatology

Volumn 62, Issue 1, 2010, Pages 54-60

  Koh, Mark Jean Aan ^a   Tay, Yong Kwang ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

corticosteroids; intravenous immunoglobulins; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CARBAMAZEPINE; CLARITHROMYCIN; CLOXACILLIN; COTRIMOXAZOLE; HYDROCORTISONE; IMMUNOGLOBULIN; LAMOTRIGINE; PENICILLIN G; PREDNISOLONE; VALPROIC ACID;

ADOLESCENT; ARTICLE; ASIAN; CELLULITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA ULCER; DEATH; DISEASE COURSE; FEMALE; GASTROENTERITIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPONATREMIA; HYPOTENSION; MALE; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; MYCOPLASMOSIS; PEDIATRIC HOSPITAL; PEDIATRICS; PERITONITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; STEVENS JOHNSON SYNDROME; TERTIARY HEALTH CARE; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LENGTH OF STAY; MALE; RETROSPECTIVE STUDIES; SINGAPORE; STEVENS-JOHNSON SYNDROME;

EID: 71649083555     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.06.085     Document Type: Article

References (34)

1. Prendiville J. Stevens-Johnson syndrome and toxic epidermal necrolysis. Adv Dermatol 18 (2002) 151-173
2. Tay Y.K., Huff C., and Weston W.L. Mycoplasma pneumoniae infection in associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol 35 (1996) 757-760
3. Schöpf E., Stuhmer A., Rzany B., Victor N., Zentgraf R., and Kapp J.F. Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 127 (1991) 839-842
4. Roujeau J.C., Guillaume J.C., Febre J.P., Penso D., Fléchet M.L., and Girre J.P. Toxic epidermal necrolysis (Lyell's syndrome) incidence and drug etiology in France, 1981-1985. Arch Dermatol 126 (1990) 37-42
5. Guillaume J.C., Roujeau J.C., Revuz J., Penso D., and Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 123 (1987) 1166-1170
6. Roujeau J.C., and Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 (1994) 1272-1285
7. Forman R., Koren G., and Shear N.H. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children - a review of 10 years' experience. Drug Safety 25 (2002) 965-972
8. Leaute-Labreze C., Lamireau T., Chawki D., Maleville J., and Taieb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 83 (2000) 347-352
9. Metry D.W., Jung P., and Levy M.L. Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics 112 (2003) 1430-1436
10. Bastuji-Garin S., Fouchard N., Bertocchi M., Roujeau J.C., Revuz J., and Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115 (2000) 149-153
11. Guegan S., Bastuji-Garin S., Poszepczynska-Guigne E., Roujeau J.C., and Revuz J. Performance of SCORTEN during the first five days of hospitalization to predict the prognosis of toxic epidermal necrolysis. J Invest Dermatol 126 (2006) 272-276
12. Kardaun S.H., and Jonkman M.F. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 87 (2007) 144-148
13. Yamane Y., Aihara M., and Ikezawa Z. Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006. Allergol Int 56 (2007) 419-425
14. Tripathi A., Ditto A.M., Grammer L.C., Greenberger P.A., McGrath K.G., Zeiss C.R., et al. Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases. Allergy Asthma Proc 21 (2000) 101-105
15. Morici M.V., Galen W.K., Shetty A.K., Lebouef R.P., Gouri T.P., Cowan G.S., et al. Intravenous immunoglobulin therapy for children with Stevens-Johnson syndrome. J Rheumatol 27 (2000) 2494-2497
16. Tristani-Firouzi P., Petersen M.J., Saffle J.R., Morris S.E., and Zone J.J. Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 47 (2002) 548-552
17. Mangla K., Rastogi S., Goyal P., Solanki R.B., and Rawal R.C. Efficacy of low dose intravenous immunoglobulins in children with toxic epidermal necrolysis: an open uncontrolled study. Indian J Dermatol Venereol Leprol 71 (2005) 398-400
18. Fiszenson-Albala F., Auzerie V., Mahe E., Farinotti R., Durand-Stocco C., Crickx B., et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 149 (2003) 1018-1022
19. Li L.F., and Ma C. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China. Clin Exp Dermatol 31 (2006) 642-647
20. Chung W.H., Hung S.I., Hong H.S., Hsih M.S., Yang L.C., Ho H.C., et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428 (2004) 486
21. Kaniwa N., Saito Y., Aihara M., Matsunaga K., Tohkin M., Kurose K., et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9 (2008) 1617-1622
22. Ferrell Jr. P.B., and McLeod H.L. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 9 (2008) 1543-1546
23. Paquet P., Jacob E., Quatresooz P., Jacquemin D., and Piérard G.E. Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis. Burns 33 (2007) 100-104
24. Mayes T., Gottschlich M., Khoury J., Warner P., and Kagan R. Energy requirements of pediatric patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Nutr Clin Pract 23 (2008) 547-550
25. Yip L.W., Thong B.Y., Lim J., Tan A.W., Wong H.B., Handa S., et al. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy 62 (2007) 527-531
26. Schneck J., Fagot J.P., Sekula P., Sassolas B., Roujeau J.C., and Mockenhaupt M. Effects of treatment on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study. J Am Acad Dermatol 58 (2008) 33-40
27. Viard I., Wehrli P., Bullani R., Schneider P., Holler N., Salomon D., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282 (1998) 490-493
28. French L.E., Trent J.T., and Kerdel F.A. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int Immunopharmacol 6 (2006) 543-549
29. Mittmann N., Chan B., Knowles S., Cosentino L., and Shear N. Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Am J Clin Dermatol 7 (2006) 359-368
30. Bachot N., Revuz J., and Roujeau J.C. Intravenous immunoglobulin for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol 139 (2003) 33-36
31. Shortt R., Gomez M., Mittman N., and Cartotto R. Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis. J Burn Care Rehabil 25 (2004) 246-255
32. Brown J.M., Silver G.M., Halerz M., Walaszek P., Sandroni A., and Gamelli R.L. Toxic epidermal necrolysis: does immunoglobulin make a difference?. J Burn Care Rehabil 25 (2004) 81-88
33. Lam N.S., Yang Y.H., Wang L.C., Lin Y.T., and Chiang B.L. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. J Microbiol Immunol Infect 37 (2004) 366-370
34. Arevalo J.M., Lorente J.A., Gonzalez-Herrada C., and Jimenez-Reyes J. Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma 48 (2000) 473-478